microcrystalline cellulose: Clinical Trials

30 trials of microcrystalline cellulose, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 4 terminated, 3 recruiting, 3 unknown. 30 Phase 2, 5 Phase 1, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 230Completed 15, Terminated 4, Recruiting 3, Unknown 3, Withdrawn 3, Active not recruiting 1, Suspended 1
Phase 15Completed 2, Recruiting 1, Unknown 1, Withdrawn 1
Phase 33Completed 1, Recruiting 1, Terminated 1

Follow microcrystalline cellulose: new trials by email Literature Review of microcrystalline cellulose trials Research Report on microcrystalline cellulose

Trials (filtered) newest first · largest first

All 30 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC)
Magnesiocard, Magnesium Diasporal, Microcrystalline cellulose - Metastatic NSCLC - Non-Small Cell Lung Cancer
Phase 2 / Phase 3RecruitingSwiss Cancer Institute2302026-09-292026-10-28
Glucose Tolerance Study
TRPTI 150mg, TRPTI 300mg, Placebo - Healthy Volunteers, Glucose Tolerance
Phase 2CompletedRDC Clinical Pty Ltd192026-03-112026-04-28
A Randomized Neuroimaging Trial of Psilocybin in Depression
Psilocybin, Microcrystalline cellulose, Supportive psychotherapy - Depressive Disorder, Major Depressive Disorder
Phase 2RecruitingSunnybrook Health Sciences Centre502025-05-282026-03-30
Nicotinic Acid for the Treatment of Alzheimer's Disease
Placebo Comparator, Extended Release Niacin - Alzheimer Disease
Phase 1 / Phase 2RecruitingIndiana University302024-12-192026-03-05
Reducing Frailty for Older Cancer Survivors Using Supplements II
Epigallocatechin-3-Gallate (EGCG), Microcrystalline cellulose (MCC), Ascorbic Acid (Vitamin C) - Frailty, Inflammation
Phase 2SuspendedUniversity of Rochester1182024-10-252026-06-26
Exploring Treatments for Children's Abdominal Pain: Comparing Trimebutine and Probiotics
Trimebutine, Lactobacillus rhamnosus, Placebo - Functional Abdominal Pain Syndrome, Functional Gastrointestinal Disorders
Phase 1 / Phase 2UnknownUniversidad de Colima822024-09-012024-08-16
Clavulanic Acid for the Treatment of Cocaine Use Disorder
Clavulanic Acid Only Product, Placebo - Cocaine Dependence
Phase 2Active not recruitingTemple University652023-05-032024-05-02
Noise-Induced Hearing Loss-Acute Exposure Treatment (UA)
Zonisamide 100Mg Cap, Placebo - Hearing Loss, Noise-Induced
Phase 2TerminatedWashington University School of Medicine32021-11-102026-02-13
The Utility of Camostat Mesylate in Patients With COVID-19 Associated Coagulopathy (CAC) and Cardiovascular Complications
Camostat Mesylate, Microcrystalline Cellulose, NF - Coagulopathy, Cardiovascular Complication
Phase 1 / Phase 2WithdrawnYale University2021-11-012022-05-18
Noise-Induced Hearing Loss-Acute Exposure Treatment
Zonisamide 100Mg Cap, Placebo - Hearing Loss, Noise-Induced
Phase 2TerminatedWashington University School of Medicine242021-10-042025-01-15
Nicotinamide Riboside in SARS-CoV-2 (COVID-19) Patients for Renal Protection
Placebo, Nicotinamide riboside - SARS-CoV-2 Infection, Acute Kidney Injury
Phase 2CompletedThe University of Texas Health Science Center at San Antonio282021-06-112023-12-26
Dose-Ranging Study to Assess the Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19
Melatonin, Placebo - COVID-19
Phase 2WithdrawnState University of New York at Buffalo2021-04-012022-07-22
A Study of Oral Ibogaine in Opioid Withdrawal
DMX-1002, Placebo - Opiate Withdrawal Syndrome
Phase 1 / Phase 2Completedatai Therapeutics, Inc.1162021-04-012024-08-06
Lamotrigine and Bupropion for Meniere's Disease
Lamotrigine and Bupropion, Placebo - Meniere Disease, Ménière's Vertigo
Phase 2UnknownDent Neuroscience Research Center342020-12-162022-06-21
KAND567 Versus Placebo in Subjects Hospitalized With COVID-19
KAND567, Microcrystalline cellulose - Covid19
Phase 2TerminatedNovakand Pharma AB352020-10-112023-08-25
The Exercise Response to Pharmacologic Cholinergic Stimulation in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome
Pyridostigmine Bromide, Placebo - Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Chronic Fatigue Syndrome
Phase 2CompletedBrigham and Women's Hospital452020-01-142022-11-08
Curcumin and Function in Older Adults
Curcumin, microcrystalline cellulose - Older Adults, Physical Function
Phase 2 / Phase 3CompletedUniversity of Florida172017-08-112022-07-26
Ramelteon in the Prevention of Post-operative Delirium
Ramelteon, Microcrystalline Cellulose, Riboflavin 100 mg - Delirium, Delirium, Dementia, Amnestic, Cognitive Disorders
Phase 2CompletedJohns Hopkins University802017-03-242020-06-30
Efficacy and Safety of 4-aminopyridine on Cognitive Performance and Motor Function of Patients With Multiple Sclerosis
4-aminopyridine, Placebo - Multiple Sclerosis
Phase 2CompletedCoordinación de Investigación en Salud, Mexico242014-10-012019-09-12
Study of Lamotrigine to Treat Ménière's Disease
Lamotrigine, Placebo - Meniere's Disease, Ménière's Vertigo
Phase 2CompletedDent Neuroscience Research Center152014-06-012022-06-22

Showing 20 of 30. Sign in to see all of them.

Conditions studied

COVID-19 (4)  ·  Dizziness (2)  ·  Hearing Loss, Noise-Induced (2)  ·  Inflammation (2)  ·  Insulin Resistance (2)  ·  Meniere Disease (2)  ·  Opioid-Related Disorders (2)  ·  Vertigo (2)  ·  Vestibular Diseases (2)  ·  Acute Kidney Injury (1)  ·  Alzheimer Disease (1)  ·  Autonomic Nervous System Diseases (1)  ·  Bronchitis (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Cocaine-Related Disorders (1)

Sponsors

Danisco (3)  ·  Dent Neuroscience Research Center (2)  ·  University of Florida (2)  ·  Washington University School of Medicine (2)  ·  Brigham and Women's Hospital (1)  ·  Columbia University (1)  ·  Coordinación de Investigación en Salud, Mexico (1)  ·  Dong-A Pharmaceutical Co., Ltd. (1)  ·  Hanlim Pharm. Co., Ltd. (1)  ·  Hospital de Egas Moniz (1)  ·  Indiana University (1)  ·  Johns Hopkins University (1)  ·  Novakand Pharma AB (1)  ·  RDC Clinical Pty Ltd (1)  ·  State University of New York at Buffalo (1)

Countries

United States (15)  ·  Finland (3)  ·  Mexico (2)  ·  South Korea (2)  ·  Australia (1)  ·  Canada (1)  ·  Denmark (1)  ·  Portugal (1)  ·  Sweden (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Craig A Buchman, MD, FACS (2)  ·  Lixin Zhang, MD, PhD (2)  ·  Aila Rissanen, MD (1)  ·  Alison Oliveto, PhD (1)  ·  Anne Lithonius (1)  ·  Anneli Tarpila, PhD (1)  ·  Arya Mani, MD (1)  ·  Bradley J MacIntosh, PhD (1)  ·  Christoph Hess, Prof MD, PhD (1)  ·  Claudia Arreola Mora, MS (1)  ·  Claudia Carvalho, PhD (1)  ·  David Systrom, MD (1)  ·  Israel Grijalva, PhD (1)

Results publications

PMID 26543027, PMID 27810310, PMID 29078780, PMID 30525950, PMID 30593980, PMID 32283645, PMID 32532654, PMID 33281447, PMID 35526605, PMID 38956594

NIH funding

P30AG028740 (2), 3UH3DK114920-04S2 (1), P50NS049060 (1), R21AG050850 (1), R21DA035325 (1), UL1TR001412 (1)